Seattle Genetics | Nakit Ve Eşdeğer



Cash And Equivalent Değişiklik Tarih
AbbVie USD 5.52B 1.73B 2024-12
Acadia Pharmaceuticals USD 681.58M 74.42M 2025-03
Agios Pharmaceuticals USD 78.96M 2.72M 2025-03
Amgen USD 8.81B 3.16B 2025-03
Astellas Pharma JPY 188.37B 8.51B 2025-03
Bayer EUR 4.02B 2.18B 2025-03
Biogen USD 2.6B 223.3M 2025-03
BioMarin Pharmaceutical USD 612.03M 1.19M 2025-03
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Celldex Therapeutics USD 17.14M 11.22M 2025-03
Daiichi Sankyo JPY 639.84B 42.31B 2025-03
Eisai JPY 265.56B 25.7B 2025-03
Eli Lilly USD 3.09B 175.1M 2025-03
Exelixis USD 183.75M 33.62M 2025-04
Genmab DKK 1.62B 8.24B 2025-03
Gilead Sciences USD 7.93B 2.06B 2025-03
GlaxoSmithKline GBP 4.46B 594M 2025-03
Glaxosmithkline GBP 3.87B 678M 2024-12
Incyte USD 2.41B 720.83M 2025-03
Insmed USD 403.25M 151.78M 2025-03
MacroGenics USD 182.84M 3.22M 2024-12
Merck USD 8.63B 4.61B 2025-03
Moderna USD 1.62B 304M 2025-03
Novartis USD 8.87B 4.74B 2024-12
Pfizer USD 1.43B 387M 2025-03
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Sanofi 7.99B 550M 2025-03
Sarepta Therapeutics USD 240.87M 862.14M 2025-03
Takeda JPY 385.11B 109.01B 2025-03
Teva Pharmaceutical Industries USD 1.7B 1.6B 2025-03
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12
Xencor USD 39.67M 1.2M 2025-03



Seattle Genetics Nakit Ve Eşdeğer - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Jul 2025.